Literature DB >> 16690190

Antidiabetic effect of garlic oil but not diallyl disulfide in rats with streptozotocin-induced diabetes.

Cheng-Tzu Liu1, Pei-Linn Wong, Chong-Kuei Lii, Hunry Hse, Lee-Yan Sheen.   

Abstract

We investigated the effects of garlic oil and diallyl disulfide (DADS) on glycemic control and renal function in rats with streptozotocin-induced diabetes. Rats received by gavage garlic oil (100 mg/kg body wt) or DADS (40 or 80 mg/kg body wt) every other day until 16 weeks after the induction of diabetes. The control rats were treated with corn oil only. Neither garlic oil nor DADS significantly affected fasting blood glucose concentrations throughout the investigation period. Garlic oil did not affect oral glucose tolerance in diabetes acutely but significantly improved oral glucose tolerance at 4, 8, 12, and 16 weeks and significantly ameliorated proteinuria at the end of 16 weeks. DADS did not significantly affect oral glucose tolerance or renal function. Diabetic rats fed 80 mg DADS/kg body wt had a significantly lower rate of body weight gain and a significantly lower ratio of muscle weight to body weight than did vehicle-treated diabetic rats. In conclusion, long-term treatment of diabetes with garlic oil can improve oral glucose tolerance and renal function in diabetes but not through the action of DADS. High doses of DADS may further complicate the metabolic disturbances in diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690190     DOI: 10.1016/j.fct.2005.07.013

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  13 in total

Review 1.  A review on the effects of Allium sativum (Garlic) in metabolic syndrome.

Authors:  A Hosseini; H Hosseinzadeh
Journal:  J Endocrinol Invest       Date:  2015-06-03       Impact factor: 4.256

Review 2.  Antidiabetic plant-derived nutraceuticals: a critical review.

Authors:  Jayapal Naveen; Vallikannan Baskaran
Journal:  Eur J Nutr       Date:  2017-10-11       Impact factor: 5.614

Review 3.  White vegetables: glycemia and satiety.

Authors:  G Harvey Anderson; Chesarahmia Dojo Soeandy; Christopher E Smith
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

4.  Preventive Effect of Garlic (Allium sativum L.) on Serum Biochemical Factors and Histopathology of Pancreas and Liver in Streptozotocin- Induced Diabetic Rats.

Authors:  Fatemeh Masjedi; Ali Gol; Shahriar Dabiri
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

5.  Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats.

Authors:  Harikesh Dubey; Anamika Singh; Angad M Patole; Chandrashekhar R Tenpe
Journal:  Integr Med Res       Date:  2016-12-16

6.  Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance.

Authors:  Razieh Jalal; Sayyed Majid Bagheri; Ali Moghimi; Morteza Behnam Rasuli
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

Review 7.  Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds.

Authors:  Peyman Mikaili; Surush Maadirad; Milad Moloudizargari; Shahin Aghajanshakeri; Shadi Sarahroodi
Journal:  Iran J Basic Med Sci       Date:  2013-10       Impact factor: 2.699

8.  A Comparison of Food-grade Folium mori ( Sāng Yè) Extract and 1-Deoxynojirimycin for Glycemic Control and Renal Function in Streptozotocin-induced Diabetic Rats.

Authors:  Shiang-Suo Huang; Yi-Hui Yan; Chien-Hui Ko; Ke-Ming Chen; Shih-Chieh Lee; Cheng-Tzu Liu
Journal:  J Tradit Complement Med       Date:  2014-07

9.  Hypoglycemic and hypolipidemic effect of S-allyl-cysteine sulfoxide (alliin) in DIO mice.

Authors:  Baiqiang Zhai; Chuanhai Zhang; Yao Sheng; Changhui Zhao; Xiaoyun He; Wentao Xu; Kunlun Huang; Yunbo Luo
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

Review 10.  An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes.

Authors:  Ajda Ota; Nataša P Ulrih
Journal:  Front Pharmacol       Date:  2017-07-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.